|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date20 Jan 1958 |
|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date04 Oct 1945 |
100 Clinical Results associated with Shire LLC
0 Patents (Medical) associated with Shire LLC
100 Deals associated with Shire LLC
100 Translational Medicine associated with Shire LLC